Completed PHASE4 INTERVENTIONAL NCT00348062
A Multicenter Evaluation of Methods to Reduce Hyperemia Associated With Bimatoprost Therapy for Glaucoma or Ocular Hypertension
Sponsor: Innovative Medical
Conditions
Glaucoma
Interventions
Bimatoprost
Updated 5 times since 2017 Last updated: May 30, 2007
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT00348062, this PHASE4 trial focuses on Glaucoma and remains completed. Sponsored by Innovative Medical, it has been updated 5 times since 2026, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE4
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Innovative Medical
Data source: Innovative Medical
For direct contact, visit the study record on ClinicalTrials.gov .